IGBMC
Gabriel Malouf is a distinguished professional in the field of oncology, currently serving as a Professor at ICANS | Institut de cancérologie Strasbourg Europe and an Adjunct Professor at MD Anderson Cancer Center since 2016. As of January 2024, Gabriel Malouf is also the Team Leader of the Molecular and Translational Oncology group at IGBMC. Previously, Gabriel held the position of Assistant Professor at Assistance publique-hôpitaux de Paris and completed a postdoctoral fellowship in cancer epigenetics at MD Anderson Cancer Center. Education includes a PhD in Molecular Genetics from Paris-Sud University, an MD from Université Paris Cité, a postdoctoral fellowship at UT MD Anderson Cancer Center, and a Master of Science in Biochemistry from Université Paris Cité.
This person is not in any teams
IGBMC
Created in 1994 by Pierre Chambon, one of the most important figures in biomedical research, the IGBMC is now one of the main European research centres in this domain. In France, it is the largest research unit, involving the CNRS, Inserm and the University of Strasbourg. In addition to its four scientific programs, the IGBMC has developed advanced scientific services and technological platforms for internal use, but also open to the wider scientific community. The Institute aims to develop interdisciplinary research at the interface of biology, biochemistry, physics and medicine, but also to attract students from around the world by offering very high-level education in the field of biomedical sciences. The IGBMC campus is located on the "Parc d'Innovation d'Illkirch" in the Strasbourg suburbs, which represents an exceptional scientific, academic and industrial environment and largely favours collaborations and technology transfer.